AES Press Releases
Rene H. Levy, Pioneer in Rational Drug Development, to Receive the AES Lennox-Lombroso Award
West Hartford, Conn., December 9, 2013– The American Epilepsy Society (AES) has announced that Rene H. Levy, Ph.D., professor emeritus and former chief of the Department of Pharmaceutics, University of Washington, has been named recipient of The William G. Lennox—Cesare T. Lombroso Award for 2013. Dr. Levy is a pioneering pharmaceutical chemist and the developer and director of the University of Washington’s Metabolism and Transport Drug Interaction Database (DIDB), a leading drug-drug interactions database used by pharmaceutical companies, regulatory agencies, research organizations and academic institutions worldwide.
Established in 1966, the Lennox-Lombroso Award is conferred by AES and the Lennox and Lombroso Trust for Research and Training in recognition of lifetime accomplishment and contributions related to epilepsy. This year’s recipient is a pioneer in understanding of the molecular processes underlying the metabolism of antiepileptic drugs, research leading to a rational approach to predicting drug-drug interactions and mechanisms of drug toxicity. The award will be presented December 9th during the AES 67th annual meeting and scientific conference at the Washington, DC, Convention Center.
Dr. Levy has published more than 300 articles with special emphasis on the absorption, distribution, elimination, toxicity and interaction potential of anticonvulsants and other medications. He is also co-editor of the classic epilepsy text Antiepileptic Drugs currently in its 5th edition, and several other leading texts in the field.
In announcing the award, John Huguenard, Ph.D., who chairs the AES awards committee, said, “We are privileged to honor Dr. Levy for the extraordinary body of work he has achieved. He has provided seminal insights that have speeded the search for new epilepsy drugs and helped to improve clinical practice in the treatment of patients with epilepsy."
The epilepsies affect 50 million people worldwide, including three million in the United States. The disorder can have a single specific, well-defined cause, such as a head injury, or manifest as a syndrome with a complex of symptoms. It is the third most common neurological disorder after Alzheimer’s disease and stroke.
About the American Epilepsy Society (AES)
The American Epilepsy Society, based in West Hartford, Conn., seeks to advance and improve the treatment of epilepsy through the promotion of epilepsy research and education for healthcare professionals. Society membership includes physicians and scientists who study and treat epilepsy (epileptologists) and allied professionals who care for people with seizure disorders.
Peter Van Haverbeke, AES Media Relations, cell 703-927-9639
Natalie Judd, Big Voice Communications, cell 203-605-9515, office 203-389-5223
203.389.5223 - firstname.lastname@example.org